ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: By measuring the expression of BCR-ABL in CML cell-derived exosomes, it could be possible to evaluate residual CML cells in the bone marrow microenvironment, thus revealing the potential role of exosomes as biomarkers.